The properties and regulation of volume-activated taurine efflux from MDA-MB-231 and MCF-7 cells have been investigated. Volume-activated taurine release from both cell lines was almost completely inhibited by diidosalicylate. DIDS , was more effective at inhibiting swelling-induced taurine release from MCF-7 than from MDA-MB-231 cells. On the basis of comparing taurine, Cl -and I -efflux time courses, it appears that volume-activated taurine efflux does not utilize volume-sensitive anion channels in MDA-MB-231 and MCF-7 cells. Extracellular ATP stimulated volume-activated taurine release from MDA-MB-231 cells but not from MCF-7 cells. The effect of ATP was mimicked by UTP and was dependent upon external calcium and inhibited by suramin. However, suramin inhibited volume-activated taurine efflux from both MDA-MB-231 and MCF-7 cells even in the absence of exogenously added ATP suggesting that it acts directly on the taurine efflux pathway and/or is inhibiting the effect of ATP released from the cells. Volumeactivated taurine efflux from MDA-MB-231 cells was stimulated by ionomycin. In contrast, ionomycin had no effect on taurine release from MCF-7 cells. Adenosine also stimulated volume-activated taurine efflux from MDA-MB-231 cells. The results suggest that purines regulate taurine transport in MDA-MB-231 cells via more than one type of receptor.
Introduction
Cell volume is constantly challenged by factors which change either the intra-or extracellular osmolality. Thus, cell volume can be altered by exposing cells to anisosmotic conditions or by changing the rate of substrate transport and oxidative metabolism [1] . Cells are, however, able to regulate their volume following a change to their hydration state. This is accomplished by a net efflux or uptake of solutes together with osmotically obliged water [2] . For example, membrane transport processes involved in volume regulation following cell swelling include K + and Cl -channels, (K + -Cl -) co-transport and a mechanism which transports organic osmolytes, including amino acids. 114 The β-amino acid taurine is a paradigm substrate of the volume-activated organic osmolyte efflux pathway [3, 4] . The nature of the volume-activated taurine efflux pathway is, however, a matter of controversy. On the one hand it has been suggested that swelling-induced taurine release utilizes volume-activated chloride channels (eg see [5, 6] ). On the other hand there is evidence suggesting that volume-activated taurine efflux is independent from chloride channels (eg see [7] [8] [9] ).
Although cells have to regulate their volume within relatively narrow limits to survive, it is apparent that cell volume per se is an important signalling factor involved in the regulation of key metabolic processes such as protein synthesis and lipogenesis [10] . The activity and regulation of volume-activated membrane transport systems play a key role in the control of cell growth and proliferation. It is also becoming apparent that cell volume, and thus volume-activated solute transport, plays a paramount role in programmed cell death [11] . It appears that a reduction of cell volume under isosmotic conditions, induced by the activation of transport mechanisms normally activated by cell swelling, is one of the earliest events in the apoptotic cascade [11, 12] .
A thorough understanding of the mechanisms underlying volume regulation could help develop strategies aimed at controlling the growth of tumour cells. In this regard, we are investigating the properties and regulation of volume-activated transport processes in two cultured human breast cancer cell lines, namely, MDA-MB-231 and MCF-7 cells which are established models for estrogen receptor-negative and -positive breast cancer cells respectively. We have recently studied the regulation of K + transport in these cells [13] . In this report we describe swelling-induced taurine efflux from MDA-MB-231 and MCF-7 cells. In particular we have investigated the relationship between taurine efflux and chloride channels and the regulation of volume-activated taurine release by extracellular ATP.
Materials and Methods
Cell Culture MDA-MB-231 and MCF-7 cells were cultured in Dulbeccos Modified Eagle Medium (DMEM) supplemented with L-glutamine (2 mM), heat-inactivated fetal bovine serum (10%), penicillin (50 IU/ml) and streptomycin (50 µg/ml). Cells were cultured in a gas phase of air with 5% CO 2 at 37 o C. Cells were seeded in 35 mm culture wells containing 2 ml of culture medium and were used when they had reached 60-90% confluency.
Taurine efflux
Taurine efflux was measured from MDA-MB-231 and MCF-7 cells using a modification of the method described by Shennan et al [14] . Briefly, cells were loaded with radiolabelled taurine by incubating in a buffer containing (mM) 135 NaCl, 5 KCl, 2 CaCl 2 , 1 MgSO 4 , 10 glucose and 10 Tris-MOPS, pH 7.4 plus 1 µCi/ml [ 3 H]taurine (35 nM) for 60 min at 37 o C. The loading buffer was aspirated and the cells were washed four times in rapid succession with a buffer similar in composition to that just described except that it contained no radioactivity. The efflux of radiolabelled taurine from the cells was measured by the sequential addition and removal of 2 ml of medium (see figure legends for precise details of composition) at 1 min intervals at 37 o C. The cells were lysed after the wash-out period by incubating in 2 ml of distilled water for at least 3 h. The wash-out samples and the lysate were prepared for counting by adding 10 ml of UltimaGold liquid scintillation cocktail. The fractional efflux for each collection period was calculated according to the method descibed by Shennan et al [8] . Preleminary experiments established that taurine efflux from MDA-MB-231 and MCF-7 cells, measured under isosmotic conditions, followed first order kinetics and thus could be described by a single mono-exponential equation (results not shown). In subsequent experiments, taurine efflux was allowed to proceed for 4 min prior to testing the effect of a hyposmotic shock.
Chloride and Iodide efflux
Chloride and iodide efflux was measured from MDA-MB-231 and MCF-7 cells respectively using I. The method for measuring the efflux of each isotope was the same as that described for taurine efflux.
Solutions
The isosmotic solution (osmolality 299 mOsmoles/kg water; range 295-307 mOsmoles/kg water) contained (mM) 135 NaCl, 5 KCl, 2 CaCl 2 , 1 MgSO 4 , 10 glucose and 10 Tris-MOPS, pH 7.4. The hyposmotic solutions were similar in composition except that they contained either 75 mM or 100 mM NaCl and had an osmolality of 186 mOsmoles/kg water (range 179-192) and 245 mOsmoles/kg water (range 230-240) respectively. The osmolality of the solutions was measured using an MicroOsmometer (Vitech Scientific LTD UK). Purinergic agonists were dissolved directly in the isosmotic and hyposmotic buffers no more than 60 min prior to use.
Statistics
Results are presented as means ± SEM. Differences were assessed using Student's paired or unpaired t-test as appropriate and were considered significant when P < 0.05. Inhibition of volume-sensitive taurine efflux was calculated from the areas under the curves after correction for basal efflux had been made. The first step in the investigation was to establish whether or not swelling-induced taurine efflux utilizes volume-activated chloride channels. Therefore, we 1) examined the effect of volume-activated anion channel inhibitors on taurine efflux and 2) compared the time courses of volume-activated taurine, chloride and iodide release. Reducing the osmolality of the incubation medium by 38% increased the fractional loss of taurine from both MDA-MB-231 and MCF-7 cells (Fig 1) . The profile of volumesensitive taurine efflux differed between the two cell types. Swelling-induced taurine release from MDA-MB-231 cells increased to reach a maximum value 2-3 min after the administration of the osmotic shock and declined thereafter. The fractional efflux was increased (basalto-peak) from 0.0212 ± 0.0073 min (± SE, n=3, P <0.001). Volume-activated taurine efflux from MCF-7 cells reached a maximum value 3 min after the cells were exposed to an osmotic shock and remained at or near the maximum level for the remainder of the time-course: the fractional loss of taurine (basal-to-peak) was increased from 0.0157 ± 0.0044 min (± SE, n=3, P < 0.01). The stilbene derivative DIDS, an established inhibitor of volume-activated anion channels, blocked volume-activated taurine efflux from both MDA-MB-231 and MCF-7 cells in a dose-dependent manner (Fig 1) . DIDS at a concentration of 50 µM, 100 µM and 1000 µM respectively inhibited the volume-dependent moiety of taurine efflux from MDA-MB-231 cells by 29.4 ± 6.2%, 38.3 ± 2.9% and 45.6 ± 6.9% (IC 50 > 1000 µM). Volume-activated taurine efflux from MCF-7 cells was more sensitive to DIDS, thus, the compound at 50 µM, 100 µM and 1000 µM respectively blocked taurine efflux by 65.8 ± 7.2%, 82.9 ± 6.5% and 96.1 ± 2.6% (IC 50 < 50 µM). Taurine efflux, under isosmotic conditions, from MDA-MB-231 and MCF-7 cells was not inhibited by DIDS (Fig 1) . Fig. 2 shows that diiodosalicylate, an inhibitor of volume-activated chloride channels in neutrophils [15] , reduced volume-activated taurine release from MDA-MB-231 and MCF-7 cells in a dose-dependent fashion. Diiodosalicylate at a concentation of 100 µM and 1000 µM respectively reduced taurine efflux from MDA-MB-231 cells by 46.3 ± 6.1% and 91.9 ± 1.3%. Taurine release from MDA-MB-231 under isosmotic conditions cells was unaffected by diiodosalicylate (Fig 2a) . Volume-activated taurine A B release from MCF-7 cells was reduced by 77.8 ± 1.8% and 97.7 ± 1.9% respectively by 100 µM and 1000 µM diiodsalicylate.On the othe hand, diiodosalicylate appeared to stimulate taurine efflux from MCF-7 cells incubated in an isosmotic buffer (Fig 2b) .
The effect of a hyposmotic challenge on Cl The effect of ATP on volume-activated taurine release Extracellular ATP stimulates osmolyte efflux from a variety of cells under both isosmotic and hyposmotic conditions [4] . In view of this, we examined the effect of ATP on taurine release from MDA-MB-231 and MCF-7 cells. Extracellular ATP had no effect on taurine release from MDA-MB-231 cells under isosmotic conditions (results not shown). In contrast, extracellular ATP stimulated the hyposmotically-sensitive portion of taurine efflux P < 0.01) (Fig 4a) .Volume-activated taurine efflux Fig. 4 . a) Taurine efflux from MDA-MB-231 cells exposed to an osmotic shock (-38%) in the absence ( ) and presence of 10 µM ( ) and 100 µM( ) ATP. The composition of the isosmotic and hyposmotic buffers was the same as those described in Fig.1 . Each point is the mean ± SE of 3 experiments. b) Taurine efflux from MDA-MB-231 cells exposed to a 21% hyposmotic shock in the absence ( ) and presence of 100 µM ATP ( ) or 100 µM UTP ( ).The isosmotic buffer was the same as that described in Fig.1 . The hyposmotic buffer was similar in composition to the isosmotic buffer except that the NaCl concentration was reduced to 100 mM. Each point is the mean ± SE of 4 experiments.
(basal-to-peak response) in the absence and presence of ATP at a concentration of 10 µM and 100 µM was respectively 0.1816 ± 0.0176 min (± SE, n=3). It is apparent from Fig. 4a that extracellular ATP also increased the rate of inactivation of volume-sensitive taurine efflux from MDA-MB-231 cells. Extracellular ATP (100 µM) also increased taurine efflux from MDA-MB-231 cells exposed to a 21% hyposmotic shock (P < 0.01) (Fig 4b) . Swelling-induced taurine efflux (basal-to-peak response) in the absence and presence of extracellular ATP was respectively 0.0209 ± 0.0019 min ( Fig 4b) . UTP, like ATP also enhanced the rate of inactivation of taurine efflux in the latter part of the time-course. In contrast, volumeactivated taurine efflux from MCF-7 cells was largely unaffected by extracellular ATP (Fig 5) . However, it was apparent that ATP reduced volume-activated taurine efflux in the latter part of the time-course.
The effect of extracellular ATP on swelling-induced taurine efflux from MDA-MB-231 cells was partially dependent upon external Ca removal from the incubation buffer on taurine efflux in the presence of extracellular ATP. Calcium removal decreased the effect of extracellular ATP on volumesensitive taurine release. It is notable that long-term calcium removal had a larger effect on the ATP-sensitive portion of efflux (P < 0.05). Ionomycin (1 µM) had only a (± SE, n = 4, P < 0.05). Taurine release from MDA-MB-231 cells under hyposmotic conditions was markedly stimulated (P< 0.01) by ionomycin (Fig 7a) . Ionomycin, like ATP also increased the rate of inactivation of taurine efflux in the latter part of the time-course (Fig 7a) . In contrast, ionomycin had no effect on volume-activated taurine efflux from MCF-7 cells (Fig7b). Suramin inhibited (P < 0.001) the effect of ATP on swelling-induced taurine efflux from MDA-MB-231 cells (Fig 8a) . Note, however, that suramin also inhibited (P < 0.01) volume-activated taurine release from MDA-MB-231 cells in the absence of exogenously added extracellular ATP. In this connection, suramin inhibited (P < 0.001)volume-activated taurine release from MCF-7 cells (Fig 8b) . Suramin also inhibited taurine efflux from MCF-7 cells under isosmotic conditions (P < 0.01).
The effect of adenosine on taurine efflux
Extracellular adenosine (100 µM) stimulated taurine efflux from MDA-MB-231 cells which had been exposed to either a 38% or 21% osmotic shock (Fig 9) . Adenosine increased the fractional efflux (peak response) from (5 min) and long-term (~ 90 min) calcium removal on volume-activated taurine efflux in the presence of 100 µM ATP from MDA-MB-231 cells exposed to a 21% hyposmotic shock. The composition of the isosmotic buffer was the same as that described in Fig. 1 . The hyposmotic buffer was similar to the isosmotic solution except that the NaCl concentration was reduced to 100 mM. Values shown represent the basal-to-peak differences. Each point is the mean ± SE of 3-4 experiments. (±SE, n=4, P < 0.05) when the cells were exposed to a 38% osmotic challenge (Fig 9a) . The fractional efflux of taurine (peak response) from cells exposed to a 21% osmotic shock was increased from 0.0412 ± 0.0028 8 . a) the effect of suramin (0.5 mM) on taurine efflux from MDA-MB-231 cells exposed to a 38% hyposmotic shock in the absence ( , + suramin ) and presence ( , + suramin ) of extracellular ATP (100 µM). The composition of the buffers were the same as those described in Fig 1. Each point is the mean ± SE of 3 experiments. b) taurine efflux from MCF-7 cells exposed to a 38% hyposmotic shock in the absence ( ) and presence ( ) of suramin (0.5 mM). Each point is the mean ± SE of 4 experiments. Fig. 9 . a) The effect of a 38% reduction in the external osmolality on taurine release from MDA-MB-231 cells in the absence ( ) and presence ( ) of adenosine (100 µM). The composition of the buffers is the same as those described in Fig 1. B) the effect of a 21% osmotic shock on taurine release from MDA-MB-231 cells in the absence ( ) and presence ( ) of adenosine (100 µM). The composition of the buffers is the same as those described in Fig. 5b . Each point is the mean ± SE of 4 experiments. min -1 to 0.0917 ± 0.0111 min -1 (± SE, n=4, P < 0.05) by the addition of adenosine (Fig 9b) .
Discussion
Relationship between swelling-induced taurine and chloride efflux It has been suggested that swelling-activated taurine efflux utilizes volume-sensitive chloride channels. This notion is based primarily on the effect of pharmacological agents and to a lesser extent on electrophysiological evidence. The finding that volume-activated taurine efflux is inhibited by chloride channel blockers such as DIDS and NPPB was initially taken as evidence for a common pathway [5, 16] . Whole-cell patch clamp studies have also shown that taurine efflux is able to permeate chloride channels [6, [17] [18] [19] . The present finding that swellinginduced taurine efflux from both MDA-MB-231 and MCF-7 cells is inhibited by chloride channel blockers such as DIDS and diiodosalicylate does constitute prima facie evidence for a shared pathway. However, chloride channel [22] have shown that volume-activated chloride and taurine efflux from HeLa cells have different time courses and therefore concluded that they do not share a common pathway. Other studies have suggested that volumesensitive taurine efflux does not always utilize anion channels. It is apparent that taurine efflux in Ehrlich Ascites cells [7] , lactating rat mammary tissue [8, 9] , skate erythrocytes [23] , supraoptic glial cells [24] , C6 glioma cells [25] and cultured human intestinal epithelial cells [26] is independent from volume-activated chloride channels. It is also claimed that volume-activated taurine efflux from some cell types is via an anion exhanger [27] .
The finding that DIDS had a much greater effect on taurine release from MCF-7 cells than MDA-MB-231 cells suggests that latter expresses more than one route for volume-activated taurine efflux: one which is sensitive to DIDS and one or more which is not inhibited by the stilbene derivative. In relation to this, it has been reported that swelling-induced taurine release from mouse blastocysts and intestinal 407 cells is not inhibited by DIDS [26, 28] . Recent evidence suggests that Caco-2 cells express more than one volume-activated taurine efflux pathway [29] . It is apparent that Caco-2 cells possess a tamoxifen-sensitive, volume-activated taurine efflux pathway on the apical membrane and a tamoxifeninsensitive, volume-activated, taurine release pathway on the basolateral membrane.
The regulation of taurine efflux by extracellular ATP and adenosine Extracellular ATP has been shown to modulate volume-activated transport processes, including taurine efflux, from a variety of cell types although the effect is by no means uniform [4] . Several groups have studied the association between extracellular ATP and volumesensitive taurine efflux and the relationship appears to be complex and dependent upon cell type: some studies have reported a stimulation of taurine release by ATP [19, 30, 31] , some have found that ATP inhibits taurine efflux [24] whereas others have found no effect [26] . The present study shows that MDA-MB-231 and MCF-7 cells differed in their response to extracellular ATP. Volumesensitive taurine release from MDA-MB-231 cells was stimulated by ATP whereas taurine efflux from MCF-7 cells was unaffected. The lack of an effect of extracellular ATP on taurine release from MCF-7 cells is surprising given that MCF-7 cells appear to express P2 receptors and that I -efflux can be stimulated by ATP under isosmotic conditions [32] . However, in our hands, extracellular ATP had no effect on I -efflux from MCF-7 cells incubated in an isosmotic or a hyposmotic buffer (Shennan & Thomson, unpublished observations [13] and secondly, ionomycin under isosmotic conditions did not mimic the effect of ATP on taurine efflux from MDA-MB-231 cells. In contrast, ionomycin had a similar effect to ATP on taurine efflux from MDA-MB-231 cells measured under hyposmotic conditions. It appears that swelling-induced taurine release has to be activated before extracellular ATP can exert its effect on taurine efflux. It is possible that extracellular ATP makes volumeactivated taurine efflux from MDA-MB-231 cells more sensitive to an osmotic shock. A similar conclusion was recently reached by Franco et al [31] who studied the effect of ATP on taurine efflux from Swiss 3T3 fibroblasts.
ATP and UTP enhanced the inactivation rate of swelling-induced taurine efflux from MDA-MB-231 cells in the latter stages of the time-course. This may be related to the effect of ATP and UTP on K is stimulated by extracellular ATP under both isosmotic and hyposmotic conditions. It is predicted that ATP and UTP will stimulate the rate of volume regulation in MDA-MB-231 cells which in turn abrogates the need for volume-activated taurine efflux [33] . Alternatively, the inactivation of taurine efflux may be an inherent property of the transport pathway.
We found that suramin inhibited volume-activated taurine efflux from MDA-MB-231 cells even in the absence of exogenously added ATP. In addition, suramin blocked volume-sensitive taurine efflux from MCF-7 cells. There are at least two explanations for this. Suramin could be acting directly on the volume-activated pathway to inhibit taurine efflux and not necessarily via P2 receptors [19] . Alternatively, suramin could be inhibiting the effect of ATP released from cultured human breast cancer cells as a consequence of cell swelling. It is well documented that ATP released from cells following cell swelling is able to activate membrane transport pathways (eg see [34] ).
The results show that adenosine stimulated volumesensitive taurine efflux from MDA-MB-231 cells. This is consistent with the recent report by Panjehpour et al [35] which describes the presence of functional A 2B adenosine receptors in MDA-MB-231 cells. The finding that extracellular adenosine was not as effective as ATP at stimulating taurine release suggests that the effect of ATP on taurine efflux is not due to hydrolysis of ATP to adenosine. Furthermore, it is unlikely that adenosine is acting via the ATP receptor. It would appear, therefore, that the control of volume-activated taurine efflux in MDA-MB-231 cells by purines involves more than one type of receptor. 
